C. Hamilton

C. Hamilton, J. Crump, J. Bartlett, 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

A Portfolio Model of Drug Development for Tuberculosis

S. Glickman, C. Hamilton, K. Schulman, 2006, Science.

Advances in basic and translational tuberculosis research: Proceedings of the first meeting of RePORT international.

C. Hamilton, D. Sherman, S. Stoszek, 2017, Tuberculosis.

Current issues in global tuberculosis control.

C. Hamilton, R. Frothingham, J. Stout, 2005, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Distributing US health aid.

C. Hamilton, K. Mayer, 2009, JAMA.

The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapse.

C. Hamilton, N. Schluger, A. Vernon, 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

A randomized controlled trial of standard versus intensified tuberculosis diagnostics on treatment decisions by physicians in Northern Tanzania

C. Hamilton, S. Chow, J. Crump, 2014, BMC Infectious Diseases.

Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting.

C. Hamilton, D. Christopher, J. Andrews, 2018, Tuberculosis.

RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration.

C. Hamilton, D. Christopher, S. Swaminathan, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Infectious complications of treatment with biologic agents

C. Hamilton, 2004, Current opinion in rheumatology.

Mortality before or during treatment among tuberculosis patients in North Carolina, 1993-2003.

C. Hamilton, J. Stout, Q. Xia, 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Chronic illness and sexual functioning.

C. Hamilton, P. Lenahan, M. Nusbaum, 2003, American family physician.

Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis.

C. Hamilton, A. Cheng, J. Stout, 2003, American journal of respiratory and critical care medicine.

Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial.

R. Chaisson, C. Hamilton, T. Sterling, 2017, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Excessive Use of Vancomycin: A Successful Intervention Strategy at an Academic Medical Center

C. Hamilton, R. Drew, S. Janning, 2000, Infection Control & Hospital Epidemiology.

Tackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis.

C. Hamilton, D. Holland, J. Stout, 2016, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Determining the Incidence of Hepatitis C Virus Infection in Populations: An Important Tool for Epidemic Control.

C. Hamilton, C. Morrison, T. Mastro, 2016, The Journal of infectious diseases.

Racial and ethnic disparities in pediatric tuberculosis in North Carolina.

C. Hamilton, J. Stout, S. Nageswaran, 2006, Archives of pediatrics & adolescent medicine.

Alcohol use and clinical manifestations of tuberculosis.

C. Hamilton, J. Stout, C. Fiske, 2008, The Journal of infection.

Antiretroviral Therapy Enrollment Characteristics and Outcomes Among HIV-Infected Adolescents and Young Adults Compared with Older Adults — Seven African Countries, 2004–2013

C. Hamilton, F. Wabwire-mangen, D. Bangsberg, 2014, MMWR. Morbidity and mortality weekly report.

Antiretroviral therapy effects on genetic and morphologic end points in lymphocytes and sperm of men with human immunodeficiency virus infection.

D. Dunson, J. Haseman, C. Hamilton, 2001, The Journal of infectious diseases.

A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solution.

C. Hamilton, J. Perfect, Melissa D. Johnson, 2003, The Journal of antimicrobial chemotherapy.

Mycobacterium avium Complex Disease

C. Hamilton, J. Stout, 2011 .

Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia*

Boping Zhou, C. Hamilton, Xilong Deng, 2016, Critical care medicine.

The proactive sexual health history.

C. Hamilton, M. Nusbaum, 2002, American family physician.

Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant.

C. Hamilton, V. Johnson, C. Petropoulos, 2001, The Journal of infectious diseases.

Differences Between HIV-Infected Men and Women in Antiretroviral Therapy Outcomes — Six African Countries, 2004–2012

C. Hamilton, F. Wabwire-mangen, D. Bangsberg, 2013, MMWR. Morbidity and mortality weekly report.

Trends in Prevalence of Advanced HIV Disease at Antiretroviral Therapy Enrollment — 10 Countries, 2004–2015

A. Abdul-Quader, C. Hamilton, S. Lyss, 2017, MMWR. Morbidity and mortality weekly report.

Reactivation of retinal toxoplasmosis despite evidence of immune response to highly active antiretroviral therapy.

C. Hamilton, J. Stout, J. Lai, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

MCP1 SNPs and Pulmonary Tuberculosis in Cohorts from West Africa, the USA and Argentina: Lack of Association or Epistasis with IL12B Polymorphisms

Scott M. Williams, J. Gilbert, G. Sirugo, 2012, PloS one.

Corrigendum to Alcohol use and clinical manifestations of tuberculosis [J Infect 57 (2008) 385―391]

C. Hamilton, J. Stout, C. Fiske, 2009 .

Extrapulmonary tuberculosis, human immunodeficiency virus, and foreign birth in North Carolina, 1993 – 2006

C. Hamilton, J. Stout, A. Van Rie, 2008, BMC public health.

The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.

M. Lederman, C. Hamilton, R. Gelman, 2007, Archives of internal medicine.

LTBI: New Options for Short Course Treatment

C. Hamilton, 2011 .

Interleukin 12B (IL12B) Genetic Variation and Pulmonary Tuberculosis: A Study of Cohorts from The Gambia, Guinea-Bissau, United States and Argentina

Scott M. Williams, J. Gilbert, G. Sirugo, 2011, PloS one.

A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment.

C. Hamilton, T. Sterling, A. Vernon, 2002, American journal of respiratory and critical care medicine.

Antepartum or Postpartum Isoniazid Treatment of Latent Tuberculosis Infection

C. Hamilton, E. Myers, K. Boggess, 2000, Obstetrics and gynecology.

Recent developments in epidemiology, treatment, and diagnosis of tuberculosis

C. Hamilton, 1999, Current infectious disease reports.

Epidemiology of Human Immunodeficiency Virus Testing Among Patients With Tuberculosis in North Carolina

C. Hamilton, J. Stout, K. Southwick, 2002, Southern medical journal.

Hospital Management of Tuberculosis in a Region With a Low Incidence of Tuberculosis and a High Prevalence of Nontuberculous Mycobacteria

C. Hamilton, B. Alexander, L. Reller, 2001, Infection Control & Hospital Epidemiology.

Tuberculosis knowledge and attitudes among physicians who treat young children in North Carolina, USA.

C. Hamilton, E. Walter, Truls Østbye, 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Effect of improving the quality of radiographic interpretation on the ability to predict pulmonary tuberculosis relapse.

John L. Johnson, C. Hamilton, A. Kosinski, 2010, Academic radiology.

Obstetri & Ginekologi Panduan Praktik

C. Hamilton, G. Morgan, 2009 .

Reply to Seddon, Schaaf, and Hesseling.

K. Dooley, C. Hamilton, Sarita Shah, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association of SLC11A1 with tuberculosis and interactions with NOS2A and TLR2 in African-Americans and Caucasians.

J. Gilbert, C. Hamilton, W. Scott, 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Tuberculosis transmission from a patient with skin lesions and a negative sputum smear.

C. Hamilton, J. Stout, J. Engemann, 2004, The New England journal of medicine.

NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans

Carol D. Hamilton, John R. Gilbert, William K. Scott, 2009, Human Genetics.

Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.

C. Hamilton, E. Hershfield, R. Reves, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Clinical research and development of tuberculosis diagnostics: moving from silos to synergy.

Wendy S Stevens, Jane Diefenbach, David Alland, 2012, The Journal of infectious diseases.

Clinical Research and Development ofTuberculosis Diagnostics: Moving From Silos toSynergy

M. Perkins, G. Ireton, C. Hamilton, 2012 .

Trends in Prevalence of Advanced HIV Disease at Antiretroviral Therapy Enrollment - 10 Countries, 2004-2015.

A. Abdul-Quader, C. Hamilton, S. Lyss, 2017 .

Over‐ and under‐treatment of TB patients in Eastern China: an analysis based on health insurance claims data

C. Hamilton, H. Lucas, S. Huan, 2019, Tropical medicine & international health.

Three months of rifapentine and isoniazid for latent tuberculosis infection.

J. Hackman, R. Chaisson, M. Conde, 2011, The New England journal of medicine.

Data Standards: At the Intersection of Sites, Clinical Research Networks, and Standards Development Initiatives

Anita Walden, Meredith Nahm, Robert A. Harrington, 2007 .

Mycobacterium bovis peritonitis mimicking ovarian cancer in a young woman.

C. Hamilton, A. Berchuck, J. Stout, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Standardising clinical data elements

William Edward Hammond, Anita Walden, Meredith Nahm, 2010, Int. J. Funct. Informatics Pers. Medicine.

Data Standards: At the Intersection of Sites, Clinical Research Networks, and Standards Development Initiatives

Brian J. McCourt, W. E. Hammond, C. Hamilton, 2007 .

Therapeutic Drug Monitoring of Antimycobacterial Drugs in Patients with Both Tuberculosis and Advanced Human Immunodeficiency Virus Infection

C. Hamilton, A. Weintrob, D. Holland, 2009, Pharmacotherapy.

Differences Between HIV-Infected Men and Women in Antiretroviral Therapy Outcomes — Six African Countries, 2004–2012

C. Hamilton, F. Wabwire-mangen, D. Bangsberg, 2013, MMWR. Morbidity and mortality weekly report.